Evaluation of Children With Endocrine and Metabolic-Related Conditions
NCT02769975 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000
Last updated 2026-04-24
Summary
Background:
Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes contain DNA, which is the blueprint of how a cell works. Researchers want to identify the genes involved in endocrine and metabolic disorders. This might help develop new ways to diagnose and treat the disorders.
Objective:
To study the inheritance of endocrine or metabolism disorders.
Eligibility:
Children ages 3month-18 with known or suspected endocrine or metabolism disorders.
Family members ages 3months-100. They may participate in the DNA part of the study.
Design:
Participants will be screened with a review of their medical records. Their parents or guardians will allow the records to be released.
Participants will have a clinic visit. This may include a physical exam and medical history.
Parents or guardians will give their consent for the study. Participants may have tests, surgery, or other procedures to help diagnose or treat their condition. These could include:
Blood, urine, and saliva tests
Growth hormone test
Pituitary and adrenal function tests
Picture of chromosomes
Imaging tests. These may include X-ray, ultrasound, scans, or a skeletal survey.
Genetic tests
Sleep study
Medical photographs
If surgery is done, a tissue sample will be taken.
Participants may have follow-up visits for diagnosis and treatment.
Participating relatives will have one visit. This will include medical history and blood and saliva tests. The blood and saliva will be used for DNA testing.
Conditions
- Adrenal Insufficiency
- Growth Disorder
- Endocrine Diseases
- Metabolic Disease
- Bone Diseases, Metabolic
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Catherine M Gordon, M.D. · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility
- Min Age
- 3 Months
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-12
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
NCT01165619 ·Status: TERMINATED
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
NCT00140413 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Appetite Regulation in Children With Failure to Thrive
NCT02647580 ·Status: COMPLETED
-
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
NCT03709381 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
NCT00004335 ·Status: COMPLETED
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Nutrition and Hormones in Boys With Disordered Growth
NCT00102258 ·Status: COMPLETED ·Phase: PHASE2
-
Constructing an Insulin-Like Growth Factor-based Prediction Model
NCT00263445 ·Status: TERMINATED
-
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
NCT00105352 ·Status: COMPLETED ·Phase: NA
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
NCT00235599 ·Status: COMPLETED
-
The Association of Hormones and Peptides With Nutritional Consequences in Children With Feeding Difficulty.
NCT03045978 ·Status: COMPLETED
-
National Cooperative Growth Study in CKD
NCT00616278 ·Status: COMPLETED
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
rhGH Therapy on Hepatic Drug Metabolism
NCT00458991 ·Status: COMPLETED
-
Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001305 ·Status: COMPLETED ·Phase: PHASE3
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
NCT00140842 ·Status: COMPLETED
-
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
NCT00097526 ·Status: COMPLETED
-
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
NCT00194961 ·Status: TERMINATED ·Phase: PHASE4
-
Growth Hormone Secretion Following the Anaerobic Exercise
NCT01934270 ·Status: UNKNOWN ·Phase: NA